Alerts will be sent to your verified email
Verify Email
VAISHALI
|
Vaishali Pharma
|
Krebs Biochem.&Inds
|
Auro Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.61 % | 56.46 % | 15.74 % |
|
5yr average Equity Multiplier
|
2.76 | -2.97 | 1.68 |
|
5yr Average Asset Turnover Ratio
|
0.89 | 0.3 | 1.03 |
|
5yr Avg Net Profit Margin
|
3.52 % | -60.0 % | 9.45 % |
|
Price to Book
|
2.56 | 0.0 | 3.98 |
|
P/E
|
202.8 | 0.0 | 92.81 |
|
5yr Avg Cash Conversion Cycle
|
133.52 Days | -861.42 Days | 34.28 Days |
|
Inventory Days
|
6.09 Days | 115.42 Days | 40.18 Days |
|
Days Receivable
|
217.95 Days | 8.79 Days | 87.78 Days |
|
Days Payable
|
174.07 Days | 408.94 Days | 76.54 Days |
|
5yr Average Interest Coverage Ratio
|
2.44 | -5.02 | 12.13 |
|
5yr Avg ROCE
|
16.76 % | -22.06 % | 20.0 % |
|
5yr Avg Operating Profit Margin
|
6.18 % | -38.55 % | 14.46 % |
|
5 yr average Debt to Equity
|
0.6 | -2.12 | 0.3 |
|
5yr CAGR Net Profit
|
88.82 % | -7.31 % | 13.98 % |
|
5yr Average Return on Assets
|
3.1 % | -17.59 % | 9.66 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
26.32 % | 72.74 % | 52.18 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.42 % | 0.0 | 0.09 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vaishali Pharma
|
Krebs Biochem.&Inds
|
Auro Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|